What is Aurora Drug Discovery?
Aurora applies concepts from quantum mechanics and thermodynamics alongside an advanced continuous water model to evaluate solvation effects when determining the binding affinities of ligands. This approach is notably different from the conventional scoring functions that are commonly used to predict binding affinities. By incorporating both entropy and aqueous electrostatic elements into their calculations, the algorithms developed by Aurora provide notably more accurate and dependable estimates of binding free energies. The binding free energy, a key thermodynamic measure, fundamentally dictates the interaction between a ligand and a protein and is directly associated with the experimentally measurable inhibition constant (IC50). Various elements, such as electrostatic interactions, quantum phenomena, solvation dynamics, and the statistical behavior of molecules, all play a role in influencing this free energy (F). The non-additive characteristics of F arise primarily from two key components: the synergistic effects of electrostatic and solvation energies, as well as the entropy present in the system. Gaining a comprehensive understanding of these factors enhances the insight into the molecular interactions that are crucial for effective drug design and development.
Integrations
No integrations listed.
Similar Software to Aurora Drug Discovery
Foxit provides a powerful portfolio of cloud-native APIs built to help organizations streamline, secure, and scale document-centric workflows. Leveraging flexible REST-based architecture, Foxit APIs enable developers to integrate document creation, conversion, extraction, signing, and viewing capabilities directly into their applications—driving greater efficiency and reducing operational complexity.
The Foxit PDF Services API supports high-volume PDF processing tasks such as conversion, extraction, optimization, and redaction. The Document Generation API automates the creation of customized PDFs and DOCX files using dynamic templates and real-time data sources. The Foxit eSign API embeds compliant, legally binding eSignature workflows with advanced audit and tracking features. The PDF Embed API enables fully customizable in-app PDF viewing with support for annotations, forms, and secure access controls.
Together, Foxit APIs deliver a secure, scalable foundation for end-to-end document automation and digital workflow transformation.
Learn more
DbVisualizer is a universal database management solution that helps organizations of all sizes work efficiently with relational and NoSQL databases. Built for developers, DBAs, analysts, and data engineers, it scales from startups to teams managing complex environments.
The platform combines a SQL editor with autocomplete, visual query builders, and execution tools for database development and querying. An AI Assistant resolves errors and explains code, while built-in Git integration supports version control and collaboration.
Teams can customize layouts, key bindings, and UI themes, mark frequent scripts and objects as favorites, and apply configurable security settings to meet compliance requirements.
DbVisualizer connects to major databases including MySQL, PostgreSQL, SQL Server, Oracle, Snowflake, SQLite, Cassandra, and BigQuery, and runs on Windows, macOS, and Linux. With nearly 7 million downloads and Pro users in 150 countries, it's a proven fit for businesses of any size.
Learn more
SYNTHIA Retrosynthesis Software
SYNTHIA™ Retrosynthesis software, created through the collaboration of computer scientists and chemists, empowers researchers to swiftly explore new and established pathways for target molecules. This tool enables efficient scanning of numerous pathways, helping to pinpoint the most suitable options tailored to specific requirements. With advanced visualization and filtering capabilities, users can uncover the most economical route to synthesize their desired molecule. The platform also allows for the customization of search parameters, enabling the user to either exclude or emphasize particular reactions, reagents, or molecular classes. Additionally, it presents innovative and distinctive synthetic routes to construct the target compound. Users can effortlessly generate a list of commercially available starting materials needed for their synthesis projects. Furthermore, the ISO/IEC 27001 Information Security Certification ensures the utmost confidentiality, integrity, and security of all data processed within the software, providing peace of mind to its users. This commitment to data protection reinforces the software's value in the scientific community.
Learn more
3decision
3decision® is a cutting-edge cloud-hosted platform designed to serve as a centralized hub for protein structures, emphasizing effective management of structural data and advanced analytics to accelerate the identification of small molecules and biologics through structure-guided drug design.
This platform integrates and standardizes both experimental and computational protein structures from well-known public repositories like RCSB PDB and AlphaFoldDB, as well as proprietary data, while accommodating various file formats including PDBx/mmCIF and ModelCIF. Such a comprehensive strategy ensures easy accessibility to a diverse array of structural data, encompassing X-Ray, NMR, cryo-EM, and modeled structures, thereby fostering collaboration and boosting scientific research efforts.
Beyond basic storage capabilities, 3decision® enhances its entries with important metadata and sequence information, detailing aspects such as protein-ligand interactions, antibody information, and binding site features. Its sophisticated analytical tools empower researchers to pinpoint potential druggable sites, assess off-target activities, and compare binding sites, thus transforming vast structural datasets into actionable insights.
The platform's cloud-based functionality not only promotes effortless collaboration among research teams but also positions itself as an indispensable asset for driving forward drug discovery projects, ultimately contributing to the advancement of therapeutic solutions. Additionally, its user-friendly interface and robust support for data integration make it a favorite among scientists aiming for innovative breakthroughs in the field.
Learn more
Screenshots and Video
Company Facts
Company Name:
Aurora Fine Chemicals
Date Founded:
1990
Company Location:
United States
Company Website:
aurorafinechemicals.com/drug-discovery-software.html
Product Details
Deployment
SaaS
Support
Standard Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English